biospecimen__admin__batch_number	203.73.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	DC209789-836D-4B83-9F1D-07F2E328DCCC
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-EP-A3JL-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-EP-A3JL-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-EP-A3JL-01A
biospecimen__bio__biospecimen_barcode_bottom	0122967801
biospecimen__bio__day_of_creation	21
biospecimen__bio__day_of_shipment	24
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	12
biospecimen__bio__month_of_shipment	01
biospecimen__bio__pathology_report_file_name	TCGA-EP-A3JL.B277ACF9-B233-474B-975A-52FDE44F27E3.pdf
biospecimen__bio__plate_column	10
biospecimen__bio__plate_id	A214
biospecimen__bio__plate_row	D
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2012
biospecimen__shared__bcr_patient_barcode	TCGA-EP-A3JL
biospecimen__shared__patient_id	A3JL
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	5AE5BA53-89FB-42E3-BB80-6D769CCA75AF
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.2
clinical__chol_lihc_shared__albumin_result_specified_value	4.1
clinical__chol_lihc_shared__albumin_result_upper_limit	4.8
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.6
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.60
clinical__chol_lihc_shared__creatinine_upper_limit	1.10
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	9
clinical__chol_lihc_shared__fetoprotein_outcome_value	13
clinical__chol_lihc_shared__hist_hepato_carc_fact	Alcohol consumption
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.10
clinical__chol_lihc_shared__platelet_result_lower_limit	130
clinical__chol_lihc_shared__platelet_result_upper_limit	386
clinical__chol_lihc_shared__specimen_collection_method_name	Other (specify)
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	76
clinical__clin_shared__bcr_followup_barcode	TCGA-EP-A3JL-F37140
clinical__clin_shared__bcr_followup_uuid	9F81BFF2-2A0F-475F-B4E7-313D76A77AEA
clinical__clin_shared__day_of_form_completion	27
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__history_prior_surgery_type_other	Laparoscopic Partial Hepatectomy in segment 4B and 5, Laproscopic Cholecystectomy, Ultrasound guided Radiofrequency Ablation of 4cm for a 2.2cm lesion between the Left pportal vein and middle hepatic vein
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	3
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	149
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2012
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2011
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	Yes
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	35f80174-ffa0-46be-8b65-16578237edf6
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-EP-A3JL-01A-11R-A214-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	0cf17327-440e-4ffb-963f-686d2f5fcd10
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.74
gdc__analytes__analyte_id	f86cd4ce-a92a-4a21-a58d-ad706c75720c
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	a196a937-b17d-4d4a-965b-8af0f4f41367
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:40:54.554160-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	9359de28-3313-5e30-a319-cf54d9501f19
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1935
gdc__diagnoses__age_at_diagnosis	27886
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-27886.0
gdc__diagnoses__days_to_last_follow_up	303.0
gdc__diagnoses__diagnosis_id	ab2ff2c2-b4b8-5fe9-b67e-ca2ee99d8bbf
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	25.864512471655328
gdc__exposures__exposure_id	01af8d90-8aaa-5f19-a065-25eaf0dc0f44
gdc__exposures__height	168.0
gdc__exposures__weight	73.0
gdc__file_id	9c075717-85d9-4d72-b5c1-ea7d322d8e39
gdc__file_name	cb397725-dd14-428f-a0db-ea518d15ea68.mirbase21.mirnas.quantification.txt
gdc__file_size	50536
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	c58337d1f35d844acb4bfb8256a279c2
gdc__portions__is_ffpe	false
gdc__portions__portion_id	fe036e7e-92bb-4a95-850e-0f5a98e9bf2e
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	22
gdc__samples__initial_weight	570.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	B277ACF9-B233-474B-975A-52FDE44F27E3
gdc__samples__sample_id	93612bcd-f1d2-44dd-8abf-7da2865878ce
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	15.0
gdc__slides__percent_tumor_cells	85.0
gdc__slides__percent_tumor_nuclei	90.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	3cf52b04-3728-476d-8ef7-674e1f33f893
gdc__submitter_id	mirna_swap_dr11_312_MirnaExpression103766b0-3540-4f47-8629-50e2ab6699c0_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	EP
gdc__tissue_source_site__name	Christiana Healthcare
gdc__tissue_source_site__tissue_source_site_id	dbcb7cb8-b22c-5a78-9d41-b93e7eb08f05
gdc__treatments__treatment_id	64b7e03d-b69a-58c5-9355-de436007053d
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:07:49.819+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/35f80174-ffa0-46be-8b65-16578237edf6-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/35f80174-ffa0-46be-8b65-16578237edf6-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129907
manually_curated__local_md5	74f054f2a38652eb79c2a11aab726d19
manually_curated__opengdc_download_date	2018-10-16T17:12:01.000497+02:00
manually_curated__opengdc_file_md5	72947b0c68bb5aa2d43a80e2ea175661
manually_curated__opengdc_file_size	50535
manually_curated__opengdc_id	35f80174-ffa0-46be-8b65-16578237edf6-meq
manually_curated__origin_file_size	129907
manually_curated__origin_last_modified_date	Tue Oct 16 17:35:00 CEST 2018
manually_curated__origin_md5	74f054f2a38652eb79c2a11aab726d19
manually_curated__tissue_status	tumoral
